Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Barrett Esophagus × plecanatide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Gastrointestinal Neoplasms 1 Gastroesophageal Reflux 1 Barrett Esophagus 1

Interventions

Biopsy 2 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 2 polyphenon E 1 plecanatide 1 linaclotide 1 gluconic acid 1 Specimen Handling 1 Itraconazole 1 Esomeprazole 1 Erlotinib Hydrochloride 1 Endoscopy, Digestive System 1 Endoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05107219 2026-04-07

GCC Agonist Signal in the Small Intestine

University of Wisconsin, Madison

Phase 1 Completed

Gastrointestinal

Barrett Esophagus, Gastroesophageal Reflux, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡